203390
(±)-Blebbistatin
≥97% (HPLC), solid, Myosin II inhibitor, Calbiochem®
别名:
(±)-博司他汀
产品名称
(±)-Blebbistatin, (±)-Blebbistatin, CAS 674289-55-5, is a cell-permeable, selective, and reversible inhibitor of nonmuscle myosin II. Blocks cell blebbing and disrupts cell migration & cytoKinesis in vertebrate cells.
质量水平
方案
≥97% (HPLC)
表单
solid
制造商/商品名称
Calbiochem®
储存条件
OK to freeze
protect from light
颜色
yellow
溶解性
methanol: 1.5 mg/mL
100% DMSO: 100 mg/mL
90% DMSO: 75 mg/mL
运输
wet ice
储存温度
−20°C
SMILES字符串
N2(CCC3(C2=Nc4c(cc(cc4)C)C3=O)O)c1ccccc1
InChI
1S/C18H16N2O2/c1-12-7-8-15-14(11-12)16(21)18(22)9-10-20(17(18)19-15)13-5-3-2-4-6-13/h2-8,11,22H,9-10H2,1H3
InChI key
LZAXPYOBKSJSEX-UHFFFAOYSA-N
一般描述
一种可渗透细胞的化合物，作为非肌肉肌球蛋白Ⅱ的选择性、强效和可逆抑制剂。抑制人血小板（≤100 µM）的ATP酶和滑动运动，而不影响肌球蛋白轻链激酶（MLCK）的活性。已经显示出可以阻止细胞起泡并迅速破坏脊椎动物细胞中的定向细胞迁移和胞质分裂。不会破坏有丝分裂或影响收缩环的组装。也可使用50 mM（5 mg/342 µl）（±）-Blebbistatin在90% DMSO的溶液（目录号203389）。
生化/生理作用
主要靶标
ATPase
ATPase
产物不与ATP竞争。
可逆性：是
细胞可渗透性：是
靶标IC50：<100 µM 抑制人血小板的ATP酶和滑动运动
包装
用惰性气体包装
制备说明
在90% DMSO中复溶后，等分并冷冻保存（-20°C）。90% DMSO中的储备液可在-20°C下稳定保存1个月。100%DMSO中的储备溶液不稳定；临用前复溶。
其他说明
Shu, S., et al. 2005.Proc.Natl.Acad.Sci. USA102, 1472.
Kovacs, M., et al. 2004.J. Biol. Chem.279, 35557.
Straight, A.F., et al. 2003.Science299, 1743.
Cheung, A., et al. 2001.Mol.Biol. Cell Suppl.12, 271a.
Kovacs, M., et al. 2004.J. Biol. Chem.279, 35557.
Straight, A.F., et al. 2003.Science299, 1743.
Cheung, A., et al. 2001.Mol.Biol. Cell Suppl.12, 271a.
法律信息
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
储存分类代码
11 - Combustible Solids
WGK
WGK 2
闪点(°F)
Not applicable
闪点(°C)
Not applicable
Mark Sweeney et al.
International journal of molecular sciences, 24(16) (2023-08-26)
Cardiac fibrosis is a common pathological process in heart disease, representing a therapeutic target. Transforming growth factor β (TGFβ) is the canonical driver of cardiac fibrosis and was recently shown to be dependent on interleukin 11 (IL11) for its profibrotic
Antonios Georgantzoglou et al.
The Journal of cell biology, 221(8) (2022-06-23)
Migrating cells must interpret chemical gradients to guide themselves within tissues. A long-held principle is that gradients guide cells via reorientation of leading-edge protrusions. However, recent evidence indicates that protrusions can be dispensable for locomotion in some contexts, raising questions
Nathan J VanDusen et al.
Nature communications, 12(1), 4442-4442 (2021-07-23)
The forward genetic screen is a powerful, unbiased method to gain insights into biological processes, yet this approach has infrequently been used in vivo in mammals because of high resource demands. Here, we use in vivo somatic Cas9 mutagenesis to
Marie-Mo Vaeyens et al.
Cytoskeleton (Hoboken, N.J.), 77(7), 261-276 (2020-06-27)
During sprouting angiogenesis-the growth of blood vessels from the existing vasculature-endothelial cells (ECs) adopt an elongated invasive form and exert forces at cell-cell and cell-matrix interaction sites. These cell shape changes and cellular tractions require extensive reorganizations of the actomyosin
Mike B Barnkob et al.
Nature communications, 15(1), 3173-3173 (2024-04-13)
Semaphorin-3A (SEMA3A) functions as a chemorepulsive signal during development and can affect T cells by altering their filamentous actin (F-actin) cytoskeleton. The exact extent of these effects on tumour-specific T cells are not completely understood. Here we demonstrate that Neuropilin-1
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持